First Commercial Quantitative PCR Test for Lawsonia Developed by BIVI
US - The Boehringer Ingelheim Vetmedica, Inc. (BIVI) Health Management Center has developed and will offer, starting July 1, the industry’s first commercially available quantitative polymerase chain reaction (PCR) test for Lawsonia (ileitis) using fecal samples.
5 June 2015
2 minute read
By: 
